Loading company…
Semeia develops software for monitoring patients across several health conditions.
Semeia develops patient monitoring software, including Nephro Wise, Mind Wise, Onco Wise, Cardio Wise, Pneumo Wise and Rheumato Wise. Founded in 2017, the company is based in Paris, France. It raised EUR 3 million from Banque des Territoires in February 2021 and EUR 8 million from MH Innov, Orange Ventures and Banque des Territoires in December 2022.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in